Literature DB >> 27791170

Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens.

J Scott Shaffer1, Penny L Moore2,3,4, Mehran Kardar5, Arup K Chakraborty6,5,7,8,9,10.   

Abstract

Strategies to elicit Abs that can neutralize diverse strains of a highly mutable pathogen are likely to result in a potent vaccine. Broadly neutralizing Abs (bnAbs) against HIV have been isolated from patients, proving that the human immune system can evolve them. Using computer simulations and theory, we study immunization with diverse mixtures of variant antigens (Ags). Our results show that particular choices for the number of variant Ags and the mutational distances separating them maximize the probability of inducing bnAbs. The variant Ags represent potentially conflicting selection forces that can frustrate the Darwinian evolutionary process of affinity maturation. An intermediate level of frustration maximizes the chance of evolving bnAbs. A simple model makes vivid the origin of this principle of optimal frustration. Our results, combined with past studies, suggest that an appropriately chosen permutation of immunization with an optimally designed mixture (using the principles that we describe) and sequential immunization with variant Ags that are separated by relatively large mutational distances may best promote the evolution of bnAbs.

Entities:  

Keywords:  HIV; biophysics; broadly neutralizing antibodies; evolutionary biology; statistical mechanics

Year:  2016        PMID: 27791170      PMCID: PMC5111661          DOI: 10.1073/pnas.1614940113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

Review 2.  Clone: a Monte-Carlo computer simulation of B cell clonal expansion, somatic mutation, and antigen-driven selection.

Authors:  M J Shlomchik; P Watts; M G Weigert; S Litwin
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

Review 3.  Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Authors:  Penny L Moore; Carolyn Williamson; Lynn Morris
Journal:  Trends Microbiol       Date:  2015-01-05       Impact factor: 17.079

4.  Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.

Authors:  Peter Hraber; Michael S Seaman; Robert T Bailer; John R Mascola; David C Montefiori; Bette T Korber
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

Review 5.  A Blueprint for HIV Vaccine Discovery.

Authors:  Dennis R Burton; Rafi Ahmed; Dan H Barouch; Salvatore T Butera; Shane Crotty; Adam Godzik; Daniel E Kaufmann; M Juliana McElrath; Michel C Nussenzweig; Bali Pulendran; Chris N Scanlan; William R Schief; Guido Silvestri; Hendrik Streeck; Bruce D Walker; Laura M Walker; Andrew B Ward; Ian A Wilson; Richard Wyatt
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

6.  Trade-offs in antibody repertoires to complex antigens.

Authors:  Lauren M Childs; Edward B Baskerville; Sarah Cobey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

7.  Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.

Authors:  Constantinos Kurt Wibmer; Jinal N Bhiman; Elin S Gray; Nancy Tumba; Salim S Abdool Karim; Carolyn Williamson; Lynn Morris; Penny L Moore
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

8.  Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors:  Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

9.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.

Authors:  Jinal N Bhiman; Colin Anthony; Nicole A Doria-Rose; Owen Karimanzira; Chaim A Schramm; Thandeka Khoza; Dale Kitchin; Gordon Botha; Jason Gorman; Nigel J Garrett; Salim S Abdool Karim; Lawrence Shapiro; Carolyn Williamson; Peter D Kwong; John R Mascola; Lynn Morris; Penny L Moore
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more
  24 in total

1.  Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site.

Authors:  Simone Conti; Kevin J Kaczorowski; Ge Song; Katelyn Porter; Raiees Andrabi; Dennis R Burton; Arup K Chakraborty; Martin Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

2.  Optimizing immunization protocols to elicit broadly neutralizing antibodies.

Authors:  Kayla G Sprenger; Joy E Louveau; Pranav M Murugan; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

3.  How Germinal Centers Evolve Broadly Neutralizing Antibodies: the Breadth of the Follicular Helper T Cell Response.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 4.  Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.

Authors:  Laurent Verkoczy
Journal:  Adv Immunol       Date:  2017       Impact factor: 3.543

5.  From affinity selection to kinetic selection in Germinal Centre modelling.

Authors:  Danial Lashgari; Elena Merino Tejero; Michael Meyer-Hermann; Mathieu A F Claireaux; Marit J van Gils; Huub C J Hoefsloot; Antoine H C van Kampen
Journal:  PLoS Comput Biol       Date:  2022-06-03       Impact factor: 4.779

6.  Quantitative modeling of the effect of antigen dosage on B-cell affinity distributions in maturating germinal centers.

Authors:  Simona Cocco; Rémi Monasson; Marco Molari; Klaus Eyer; Jean Baudry
Journal:  Elife       Date:  2020-06-15       Impact factor: 8.140

7.  Optimal evolutionary decision-making to store immune memory.

Authors:  Oskar H Schnaack; Armita Nourmohammad
Journal:  Elife       Date:  2021-04-28       Impact factor: 8.140

8.  Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies.

Authors:  Raymond H Y Louie; Kevin J Kaczorowski; John P Barton; Arup K Chakraborty; Matthew R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

9.  Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies.

Authors:  Victor Ovchinnikov; Joy E Louveau; John P Barton; Martin Karplus; Arup K Chakraborty
Journal:  Elife       Date:  2018-02-14       Impact factor: 8.140

10.  Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination.

Authors:  Alba Torrents de la Peña; Steven W de Taeye; Kwinten Sliepen; Celia C LaBranche; Judith A Burger; Edith E Schermer; David C Montefiori; John P Moore; Per Johan Klasse; Rogier W Sanders
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.